Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Long-Term Debt Repayments (2019 - 2021)

Historic Long-Term Debt Repayments for Arcadia Biosciences (RKDA) over the last 3 years, with Q4 2021 value amounting to $114000.0.

  • Arcadia Biosciences' Long-Term Debt Repayments rose 132500.0% to $114000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.1 million, marking a year-over-year increase of 621176.47%. This contributed to the annual value of $2.1 million for FY2021, which is 621176.47% up from last year.
  • Latest data reveals that Arcadia Biosciences reported Long-Term Debt Repayments of $114000.0 as of Q4 2021, which was up 132500.0% from $13000.0 recorded in Q3 2021.
  • Arcadia Biosciences' 5-year Long-Term Debt Repayments high stood at $2.0 million for Q1 2021, and its period low was $6000.0 during Q4 2019.
  • Over the past 3 years, Arcadia Biosciences' median Long-Term Debt Repayments value was $10000.0 (recorded in 2021), while the average stood at $242888.9.
  • Within the past 5 years, the most significant YoY rise in Arcadia Biosciences' Long-Term Debt Repayments was 2860000.0% (2021), while the steepest drop was 1818.18% (2021).
  • Arcadia Biosciences' Long-Term Debt Repayments (Quarter) stood at $6000.0 in 2019, then surged by 33.33% to $8000.0 in 2020, then soared by 1325.0% to $114000.0 in 2021.
  • Its Long-Term Debt Repayments was $114000.0 in Q4 2021, compared to $13000.0 in Q3 2021 and $10000.0 in Q2 2021.